1-6 of 6
George L. Scheffer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Breast Cancer Resistance Protein in Drug Resistance of Primitive CD34+38− Cells in Acute Myeloid Leukemia

Marc H.G.P. Raaijmakers, Elke P.L.M. de Grouw, Leonie H.H. Heuver, Bert A. van der Reijden, Joop H. Jansen, Rik J. Scheper, George L. Scheffer, Theo J.M. de Witte, Reinier A.P. Raymakers
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (6): 2436–2444.
https://doi.org/10.1158/1078-0432.CCR-04-0212
Published: 23 March 2005
View article titled, Breast Cancer Resistance Protein in Drug Resistance of Primitive CD34+38− Cells in Acute Myeloid Leukemia
Open the PDF for Breast Cancer Resistance Protein in Drug Resistance of Primitive CD34+38− Cells in Acute Myeloid Leukemia in another window
Journal Articles

The Role of Breast Cancer Resistance Protein in Acute Lymphoblastic Leukemia

Sabine L. A. Plasschaert, Dorina M. van der Kolk, Eveline S. J. M. de Bont, Willem A. Kamps, Kuniaki Morisaki, Susan E. Bates, George L. Scheffer, Rik J. Scheper, Edo Vellenga, Elisabeth G. E. de Vries
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5171–5177.
Published: 12 November 2003
View article titled, The Role of Breast Cancer Resistance Protein in Acute Lymphoblastic Leukemia
Open the PDF for The Role of Breast Cancer Resistance Protein in Acute Lymphoblastic Leukemia in another window
Journal Articles

Multidrug-Resistant Tumor Cells Remain Sensitive to a Recombinant Interleukin-4- Pseudomonas Exotoxin, Except When Overexpressing the Multidrug Resistance Protein MRP1

Mariska C. de Jong, George L. Scheffer, Henk J. Broxterman, Jan H. Hooijberg, Jerry W. Slootstra, Rob H. Meloen, Robert J. Kreitman, Syed R. Husain, Bharat H. Joshi, Raj K. Puri, Rik J. Scheper
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (13): 5009–5017.
Published: 27 October 2003
View article titled, Multidrug-Resistant Tumor Cells Remain Sensitive to a Recombinant Interleukin-4- <em>Pseudomonas</em> Exotoxin, Except When Overexpressing the Multidrug Resistance Protein MRP1
Open the PDF for Multidrug-Resistant Tumor Cells Remain Sensitive to a Recombinant Interleukin-4- <em>Pseudomonas</em> Exotoxin, Except When Overexpressing the Multidrug Resistance Protein MRP1 in another window
Journal Articles

Molecular Determinants of Treatment Response in Human Germ Cell Tumors

Frank Mayer, Hans Stoop, George L. Scheffer, Rik Scheper, J. Wolter Oosterhuis, Leendert H. J. Looijenga, Carsten Bokemeyer
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (2): 767–773.
Published: 01 February 2003
View article titled, Molecular Determinants of Treatment Response in Human Germ Cell Tumors
Open the PDF for Molecular Determinants of Treatment Response in Human Germ Cell Tumors in another window
Journal Articles

Expression of the Breast Cancer Resistance Protein in Breast Cancer

Ian F. Faneyte, Petra M. P. Kristel, Marc Maliepaard, George L. Scheffer, Rik J. Scheper, Jan H. M. Schellens, Marc J. van de Vijver
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1068–1074.
Published: 01 April 2002
View article titled, Expression of the Breast Cancer Resistance Protein in Breast Cancer
Open the PDF for Expression of the Breast Cancer Resistance Protein in Breast Cancer in another window
Journal Articles

Drug Resistance-associated Markers P-Glycoprotein, Multidrug Resistance-associated Protein 1, Multidrug Resistance-associated Protein 2, and Lung Resistance Protein as Prognostic Factors in Ovarian Carcinoma

Henriette J. G. Arts, Dionyssios Katsaros, Elisabeth G. E. de Vries, Marco Massobrio, Franco Genta, Silvio Danese, Riccardo Arisio, Rick J. Scheper, Marcel Kool, George L. Scheffer, Pax H. B. Willemse, Ate G. J. van der Zee, Albert J. H. Suurmeijer
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 2798–2805.
Published: 01 October 1999
View article titled, Drug Resistance-associated Markers P-Glycoprotein, Multidrug Resistance-associated Protein 1, Multidrug Resistance-associated Protein 2, and Lung Resistance Protein as Prognostic Factors in Ovarian Carcinoma
Open the PDF for Drug Resistance-associated Markers P-Glycoprotein, Multidrug Resistance-associated Protein 1, Multidrug Resistance-associated Protein 2, and Lung Resistance Protein as Prognostic Factors in Ovarian Carcinoma in another window